hGH fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-06. Numbers and descriptions here follow the published literature rather than marketing material.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
== See also == Crick, Brenner et al. experiment – DNA structure discoveryPages displaying short descriptions of redirect targets Crick's wobble hypothesis – RNA base pair that does not follow Watson–Crick base pair rules History of RNA biology List of RNA biologists Molecular structure of Nucleic Acids – 1953 scientific paper on DNAPages displaying short descriptions of redirect targets Neural correlates of consciousness – Neuronal events sufficient for a specific conscious percept
==== United Kingdom ==== On June 10, 2014, the United Kingdom Advisory Council on the Misuse of Drugs (ACMD) recommended that ETH-LAD be specifically named in the UK Misuse of Drugs Act as a class A drug despite not identifying it as ever having been sold or any harm associated with its use. The UK Home office accepted this advice and announced a ban of the substance to be enacted on 6 January 2015.
In 2000, the NHTSA released a regulation making trunk releases mandatory for new cars by September of the following year due, in part, to the lobbying efforts of Janette Fennell. In 2003, the IIHS began conducting side impact crash tests. In 2004, NHTSA released new tests designed to test the rollover risk of new cars and SUVs. Only the Mazda RX-8 got a 5-star rating. Also in 2003, the National Highway Traffic Safety Administration (NHTSA) introduced a female counterpart crash test dummy of Hybrid III. This dummy was just a scaled-down version of the original Hybrid III, only representing the smallest 5% of women based on mid-1970s standards. In 2009, Citroën became the first manufacturer to feature "Snowmotion", an Intelligent Anti Skid system developed in conjunction with Bosch, which gives drivers a level of control in extreme ice or snow conditions similar to a 4x4. In 2009, NHTSA upgraded its roof-crush standard for vehicles weighing 6000 pounds or less. The new standard increased the crush load requirement from 1.5 to 3 times the vehicle's curb weight.
RK2 was first isolated in connection with an outbreak of antibiotic-resistant Pseudomonas aeruginosa and Klebsiella aerogenes in Birmingham in 1969, as one of a family of plasmids implicated in transfer of ampicillin resistance between bacterial strains. Plasmids in the IncP-1 subgroup has been isolated from wastewater, agricultural soil, and hospitals. RK2 is approximately 60 kbp long and contains genes for replication, maintenance, conjugation and antibiotic resistance. The resistance genes confer resistance to the antibiotics kanamycin, ampicillin and tetracycline. In addition, RK2 contains a set of potentially lethal (to the cell) genes, called kil genes, and a set of complementary transcriptional repressor genes, called kor (short for "kil-override") genes, which inactivate the kil genes. The kil and kor genes together are suspected to play a role in the broad host range of RK2.
== Bibliography == Olsen, Rolf A. (1994). "4.2. The Transfer of Radiocaesium from Soil to Plants and Fungi in Seminatural Ecosystems". Nordic Radioecology: The Transfer of Radionuclides Through Nordic Ecosystems to Man. Studies in Environmental Science. Vol. 62. pp. 265–286. doi:10.1016/S0166-1116(08)71715-1. ISBN 978-0-444-81617-7.
Sources: en.wikipedia.org
X Both the First and Second Ministries were officially referred to as the "Court–Cowan Ministry" or "Court Ministry" in Hansard and other parliamentary records. 1 On 24 August 1993, Doug Shave resigned for personal reasons. His three portfolios were distributed to three of the other ministers. 2 On 25 January 1994, the ministry returned to 17 members with the appointment of Kevin Prince. Additionally, the Premier took on the role of Minister for Tourism. 3 On 26 April 1994, parliamentary secretary Bob Pike died. His parliamentary secretary position was not refilled.
In the United States domestic market, the chain fell to third place in terms of same-store sales behind Ohio-based Wendy's. The decline was the result of 11 consecutive quarters of same store sales decline. In August 2014, 3G announced that it planned to acquire the Canadian restaurant and coffee shop chain Tim Hortons and merge it with Burger King with backing from Warren Buffett's Berkshire Hathaway. The two chains retained separate operations post-merger, with Burger King remaining in its Miami headquarters. A Tim Hortons representative stated that the proposed merger would allow Tim Hortons to leverage Burger King's resources for international growth. The combined company became the third-largest international chain of fast food restaurants. The deal led to a controversy over the practice of tax inversions, in which a company decreases the amount of taxes it pays by moving its headquarters to a tax haven, a country with lower rates, but maintains the majority of their operations in their previous location. As a high-profile instance of tax inversion, news of the merger was criticized by U.S. politicians, who felt that the move would result in a loss of tax revenue to foreign interests, and could result in further government pressure against inversions. In 2019, Burger King reported that it planned to close up to 250 low-volume locations per year, with closures coming into effect in 2020. In February 2021, Burger King began testing a customer loyalty rewards program called "Royal Perks" in Los Angeles, Miami, New York City, New Jersey, and Long Island, New York.
=== Stress and adverse life experiences === Stress may be a precipitating factor in the development of fibromyalgia. A 2018 systematic review found low quality evidence supporting an association between fibromyalgia and traumatic events, and noted a lack of prospective studies. A 2021 meta-analysis of case-control studies found abuse and other lifetime stressors to be strongly associated with fibromyalgia. People with fibromyalgia had approximately three times the odds of reporting any type of abuse, and approximately twice the odds of reporting medical trauma or other stressors. A 2024 review of violence and chronic pain in women found "strong associations between an adult history of violent victimization and chronic pain" and that "the impact of violence on fibromyalgia was significant." A 2014 review argued that existing evidence entailed too many methodological limitations, such as reliance on recollections and confounding, to support that physical trauma could cause fibromyalgia. Some of the other FM risk markers below may include stress elements.
Thalidomide Cytokine antagonists Cannabinoids Omega-3 fatty acids, including eicosapentaenoic acid (EPA) Non-steroidal anti-inflammatory drugs Prokinetics Ghrelin and ghrelin receptor agonist Anabolic catabolic transforming agents such as MT-102 Selective androgen receptor modulators Cyproheptadine Hydrazine sulfate Medical marijuana has been allowed for the treatment of cachexia in some US states, such as Missouri, Illinois, Maryland, Delaware, Nevada, Michigan, Washington, Oregon, California, Colorado, New Mexico, Arizona, Vermont, New Jersey, Rhode Island, Maine, and New York Hawaii and Connecticut.
== Background == The elections were held less than a year after the July 1921 legislative elections, in which the Republican Liberal Party (PLR) had won a majority of votes. However, on 19 October 1921 ("the night of blood"), a military coup resulted in several republican figures being killed, including PLR prime minister António Granjo. On the night of blood, President António José de Almeida invested Manuel Maria Coelho as Prime Minister, but his government resigned on 3 November. On the same day, Carlos Maia Pinto became Prime Minister, but also resigned on 16 December. Francisco Cunha Leal then served as Prime Minister until the elections. The elections took place amidst instability and violence and were postponed four times before finally taking place on 29 January.
Sources: en.wikipedia.org
In other cases, the solid reactants do not need to be melted, but instead can react through a solid-state reaction route. In this method, the reactants are repeatedly finely ground into a paste and then heated to a temperature where the ions in neighboring reactants can diffuse together during the time the reactant mixture remains in the oven. Other synthetic routes use a solid precursor with the correct stoichiometric ratio of non-volatile ions, which is heated to drive off other species. In some reactions between highly reactive metals (usually from Group 1 or Group 2) and highly electronegative halogen gases, or water, the atoms can be ionized by electron transfer, a process thermodynamically understood using the Born–Haber cycle. Salts can be formed through a variety of reaction types, such as those between:
== Description == A sizzler is essentially a single dish meal, in which meats and vegetables are cooked in a sauce on a hot metal plate. The dish has been described as an "open-roasted, grilled or shallow fried piece of meat, chicken, fish or vegetable patty, served on an oval shaped metal or stone hot plate, kept on a wooden base. The word "sizzler" comes from the sizzle that one hears after heating the dish under a grill. The metal plate is heated to the point right before service, that when the finished steak is placed on it, it sizzles and the smoky flavour makes the dish more enticing." In terms of preparation, the equipment and method for all sizzlers is the same, despite the large variety of ingredients and sauces.
Abietic acid dermatitis Acid-induced Acrylic monomer dermatitis Adhesive dermatitis African blackwood dermatitis Airbag dermatitis (airbag burn) Alkali-induced Allergic Antifungal agent-induced Antimicrobial agent-induced Arsenic dermatitis Artificial nail-induced Axillary antiperspirant-induced Axillary deodorant-induced Baboon syndrome Black dermatographism Bleaching cream-induced Capsaisin-induced Chemical burn Chloracne Chrome dermatitis Clothing-induced Cobalt dermatitis Contact stomatitis (contact lichenoid reaction, lichenoid amalgam reaction, oral mucosal cinnamon reaction) Contact urticaria Corticosteroid-induced Cosmetic dermatitis Cosmetic intolerance syndrome Dentifrice-induced Dermatitis from metals and metal salts Dust-induced Epoxy resin dermatitis Ethylenediamine-induced Eye makeup-induced Fiberglass dermatitis Flower-induced Formaldehyde-induced Formaldehyde-releasing agent-induced Fragrance-induced Gold dermatitis Hair bleach-induced Hair dye-induced Hair lotion-induced Hair spray-induced Hair straightener-induced Hair tonic-induced Houseplant-induced Hydrocarbon-induced Irritant folliculitis Lacquer dermatitis (lacquer sensitivity) Lanolin-induced Lipstick-induced Local anesthetic-induced Makassar ebony dermatitis Marine plant-induced Mechanical irritant dermatitis Mercury dermatitis Mouthwash-induced Nail lacquer-induced Nail polish remover-induced Nickel dermatitis Occupation-induced p-Chloro-meta-xylenol-induced Paraben-induced Paraphenylenediamine dermatitis Permanent wave preparation-induced Phenothiazine drug-induced Photoallergic Photoirritant Plant derivative-induced Pollen-induced Polyester resin dermatitis Propylene glycol-induced Protein contact dermatitis Quaternium-15 hypersensitivity Reed dermatitis Rosewood dermatitis Rosin dermatitis Rubber dermatitis Seed-induced Shoe dermatitis Solvent-induced Sorbic acid-induced Subjective irritant contact dermatitis (sensory irritant contact dermatitis) Sunscreen-induced Systemic contact dermatitis Tear gas dermatitis Textile dermatitis Traumatic irritant contact dermatitis Tree-associated plant-induced Tree-induced Tulip fingers Urushiol-induced Vegetable-induced
A number of drug interactions can occur between MDMA and other drugs, including serotonergic drugs. MDMA also interacts with drugs which inhibit CYP450 enzymes, like ritonavir (Norvir), particularly CYP2D6 inhibitors. Life-threatening reactions and death have occurred in people who took MDMA while on ritonavir. Bupropion, a strong CYP2D6 inhibitor, has been found to increase MDMA exposure with administration of MDMA. Concurrent use of MDMA with certain other serotonergic drugs can result in a life-threatening condition called serotonin syndrome. Severe overdose resulting in death has also been reported in people who took MDMA in combination with certain monoamine oxidase inhibitors (MAOIs), such as phenelzine (Nardil), tranylcypromine (Parnate), or moclobemide (Aurorix, Manerix). Serotonin reuptake inhibitors (SRIs) such as citalopram (Celexa), duloxetine (Cymbalta), fluoxetine (Prozac), and paroxetine (Paxil) have been shown to block most of the subjective effects of MDMA. Norepinephrine reuptake inhibitors (NRIs) such as reboxetine (Edronax) have been found to reduce emotional excitation and feelings of stimulation with MDMA but do not appear to influence its entactogenic or mood-elevating effects. MDMA induces the release of monoamine neurotransmitters and thereby acts as an indirectly acting sympathomimetic and produces a variety of cardiostimulant effects. It dose-dependently increases heart rate, blood pressure, and cardiac output.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.